AI assistant
STANDARD BIOTOOLS INC. — Director's Dealing 2023
May 18, 2023
32853_dirs_2023-05-17_76901521-d60e-4f1a-a9da-f14f2d51c530.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: STANDARD BIOTOOLS INC. (LAB)
CIK: 0001162194
Period of Report: 2023-05-15
Reporting Person: Black Jeffrey G. (SVP & Chief Financial Officer)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2023-05-15 | Restricted Stock Units | $ | A | 210526 | Acquired | Common Stock (210526.0) | Direct | |
| 2023-05-15 | Stock Option (Right to Buy) | $1.9 | A | 400000 | Acquired | 2033-05-15 | Common Stock (400000.0) | Direct |
Footnotes
F1: Each Restricted Stock Unit represents the contingent right to receive one share of LAB common stock.
F2: Restricted Stock Units vest as to 1/4 of the underlying shares on May 15, 2024, and as to an additional 1/16th of the total number of shares every three months thereafter, subject to Mr. Black's continued service through the applicable vesting date.
F3: The Option becomes exercisable as to 1/4th of the underlying shares on May 15, 2024, and as to an additional 1/48th of the total number of shares each month thereafter, subject to Mr. Black's continued service through the applicable vesting date.